Funds Holding Immunomedics, Inc.

 
Stock Quotes for Immunomedics, Inc. top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Slow Growth
Sign-up for immu investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Slow Growth
Sign-up for immu investment picks

 
News Articles for Immunomedics, Inc. top ^
2013/7/16
MORRIS PLAINS, N.J., July 16, 2013 (GLOBE NEWSWIRE) -- Immunomedics , Inc. (Nasdaq:IMMU) ,a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported the issuance of U.S. Patent 8,486,395 with expiration on August 2, 2024.
Sign-up for Immunomedics Constructs New Humanized Antibody for B-Cell Mediated Cancer and Autoimmune Diseases investment picks
2013/8/9
MORRIS PLAINS, N.J., Aug.
Sign-up for Immunomedics Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2013 Financial Results investment picks
2013/8/12
MORRIS PLAINS, N.J., Aug.
Sign-up for Immunomedics Advances Solid Tumor Antibody-Drug Conjugate Programs to Phase II Clinical Trials investment picks
MORRIS PLAINS, N.J., Aug.
Sign-up for Immunomedics Appoints Richard L. Sherman to Board of Directors investment picks
2013/8/22
MORRIS PLAINS, N.J., Aug.
Sign-up for Immunomedics Announces Fiscal 2013 Results investment picks
MORRIS PLAINS, N.J., Sept.
Sign-up for Immunomedics Appoints Peter P. Pfreundschuh as New Chief Financial Officer investment picks
2013/9/4
MORRIS PLAINS, N.J., Sept.
Sign-up for Immunomedics to Present at Stifel Healthcare Conference 2013 investment picks
2013/9/30
MORRIS PLAINS, N.J., Sept.
Sign-up for Immunomedics Confirms Funding of Department of Defense Clinical Trial Grant for Milatuzumab in Lupus investment picks
AMSTERDAM, Netherlands, Sept.
Sign-up for Immunomedics Reports Updated Results of Labetuzumab-SN-38 in Metastatic Colorectal Cancer investment picks
2013/10/10
MORRIS PLAINS, N.J., Oct.
Sign-up for Immunomedics Announces Presentations at Upcoming Conferences investment picks
2013/10/9
MORRIS PLAINS, N.J., Oct.
Sign-up for Immunomedics Announces Termination of Agreement and Return of Worldwide Rights to Veltuzumab for All Non-Cancer Indications investment picks
MORRIS PLAINS, N.J., Oct.
Sign-up for Immunomedics Develops Dendritic-Cell Vaccine Technology for Lymphomas and Leukemias investment picks
-- Partial Responses in Colorectal, Triple-Negative Breast, and Small-Cell-Lung Cancers --
Sign-up for Immunomedics Reports Multiple Objective Responses in Solid Cancers With IMMU-132 investment picks
2013/10/25
MORRIS PLAINS, N.J., Oct.
Sign-up for Immunomedics Announces 4 Presentations on Epratuzumab at 2013 American College of Rheumatology Annual Meeting investment picks
2013/10/24
MORRIS PLAINS, N.J., Oct.
Sign-up for Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2014 Financial Results investment picks
2013/11/5
MORRIS PLAINS, N.J., Nov.
Sign-up for Immunomedics Awarded Key Patent for TROP-2 Antibody investment picks
2013/11/4
MORRIS PLAINS, N.J., Nov.
Sign-up for Immunomedics Announces First Quarter Fiscal 2014 Results and Clinical Program Developments investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Funds Holding Immunomedics, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Immunogen, Inc.  |  Next: Funds Holding Inbev